30. Secondary Analysis of Sleep Functioning and Interleukin-6 Levels Between Controls and Athletes Following Sport-related Concussion
Clicks: 1
ID: 324454
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #55 of 79 articles by views in archives of clinical neuropsychology : the official journal of the national academy of neuropsychologists
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Purpose Interleukin 6 (IL 6) is an inflammatory cytokine that may be acutely elevated within the acute phase following sport related concussion. IL-6 has been an area of interest as a peripheral blood-based biomarker; however, few studies have examined IL-6 in relation to sleep functioning. We hypothesized there would be differences in sleep functioning and IL-6 levels reflected in immunoassay between concussed and control athletes. Method Data were obtained from a prospective, observational cohort study conducted on athletes at an academic institution to conduct a secondary post-hoc analysis. Participants comprised of 41 athletes diagnosed with SRC and 55 health controls for a total of 96 participants. ANCOVA was utilized to identify group differences in sleep functioning and IL-6 levels, while linear regression was used to assess the relationship between IL-6 and sleep functioning. Demographics, recovery data (i.e., time to clearance), and concussion-related symptoms were gathered via the Sport Concussion Assessment Tool - 5 (SCAT-5) Results No differences in IL-6 were observed between concussed and control athletes. IL-6 levels did not predict sleep symptoms. However, there were statistically significant differences in total symptoms, overall symptom severity, and emotional, somatic, cognitive, and sleep symptoms (all p<0.001). Conclusions Group differences in symptom burden within the sleep domain of the SCAT-5 were observed, as well as all other domains captured within the SCAT-5. An absence of differences in IL-6 levels may be attributable to small sample size or immunoassay protocol. Future research should examine this phenomenon in a larger sample and include additional biomarkers to explore other neurobiological implications for sleep architecture.
| Reference Key |
openalex_W7202075890
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | J Breton, D Luongo, A Laique, H Jasper, S Patel, A Doran, L Manderino |
| Journal | archives of clinical neuropsychology : the official journal of the national academy of neuropsychologists |
| Year | 2026 |
| DOI |
10.1093/arclin/acag055.030
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.